• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency.

作者信息

Naderi M, Dorgalaleh A, Alizadeh S, Kashani Khatib Z, Tabibian S, Kazemi A, Dargahi H, Bamedi T

机构信息

Ali Ebn-e Abitaleb Hospital Research Center for Adolescents Health, Zahedan University of Medical Sciences, Zahedan, Iran.

出版信息

Haemophilia. 2014 Jan;20(1):e89-92. doi: 10.1111/hae.12287. Epub 2013 Oct 31.

DOI:10.1111/hae.12287
PMID:24354489
Abstract
摘要

相似文献

1
Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency.凝血酶激活的纤溶抑制物多态性与因子 XIII 缺乏症患者颅内出血风险
Haemophilia. 2014 Jan;20(1):e89-92. doi: 10.1111/hae.12287. Epub 2013 Oct 31.
2
Central nervous system bleeding in pediatric patients with factor XIII deficiency: a study on 23 new cases.XIII因子缺乏的儿科患者的中枢神经系统出血：23例新病例的研究
Hematology. 2015 Mar;20(2):112-8. doi: 10.1179/1607845414Y.0000000172. Epub 2014 Jul 7.
3
Spontaneous acute cerebral hematoma in a child with factor XIII deficiency.一名患有凝血因子 XIII 缺乏症的儿童出现自发性急性脑血肿。
Pediatr Hematol Oncol. 2013 Nov;30(8):723-5. doi: 10.3109/08880018.2013.798059. Epub 2013 May 22.
4
Unusual presentation of factor XIII deficiency.因子 XIII 缺乏症的不典型表现。
Haemophilia. 2002 Sep;8(5):703-5. doi: 10.1046/j.1365-2516.2002.00658.x.
5
The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.凝血酶激活的纤溶抑制物（TAFI）基因中的遗传变异对TAFI抗原水平、血块溶解时间及静脉血栓形成风险的影响。
Br J Haematol. 2006 Jul;134(1):92-4. doi: 10.1111/j.1365-2141.2006.06117.x.
6
Factor XIII deficiency: a differential diagnosis to be considered in suspected nonaccidental injury presenting with intracranial hemorrhage.凝血因子 XIII 缺乏症：疑似非意外伤害伴颅内出血时需考虑的鉴别诊断。
Clin Pediatr (Phila). 2008 May;47(4):385-7. doi: 10.1177/0009922807309065. Epub 2007 Dec 5.
7
[Cephalohemoatoma as the first manifestation of congenital factor XIII deficiency].[头颅血肿作为先天性因子 XIII 缺乏症的首发表现]
An Esp Pediatr. 2000 Sep;53(3):241-2.
8
Association between genotype and plasma levels of thrombin-activated fibrinolysis inhibitor (TAFI) in the development of preeclampsia.在子痫前期的发生发展中，基因型与凝血酶激活的纤溶抑制物（TAFI）的血浆水平之间的关系。
Thromb Res. 2011 Oct;128(4):e39-42. doi: 10.1016/j.thromres.2011.05.019. Epub 2011 Jun 25.
9
The 1040C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor is associated with risk for oral cancer.影响凝血酶激活的纤溶抑制物热稳定性和活性的1040C/T多态性与口腔癌风险相关。
Am J Hematol. 2007 Nov;82(11):1010-2. doi: 10.1002/ajh.20985.
10
Intracranial hemorrhage pattern in the patients with factor XIII deficiency.因子 XIII 缺乏症患者的颅内出血模式。
Ann Hematol. 2014 Apr;93(4):693-7. doi: 10.1007/s00277-013-1918-7. Epub 2013 Oct 23.

引用本文的文献

1
Rivaroxaban attenuates thrombosis by targeting the NF-κB signaling pathway in a rat model of deep venous thrombus.利伐沙班通过靶向 NF-κB 信号通路减轻大鼠深静脉血栓模型中的血栓形成。
Int J Mol Med. 2017 Dec;40(6):1869-1880. doi: 10.3892/ijmm.2017.3166. Epub 2017 Sep 29.
2
The role of FV 1691G>A, FII 20210G>A mutations and MTHFR 677C>T; 1298A>C and 103G>T FXIII gene polymorphisms in pathogenesis of intraventricular hemorrhage in infants born before 32 weeks of gestation.FV 1691G>A、FII 20210G>A突变以及MTHFR 677C>T、1298A>C和103G>T FXIII基因多态性在孕32周前出生婴儿脑室内出血发病机制中的作用。
Childs Nerv Syst. 2017 Jul;33(7):1201-1208. doi: 10.1007/s00381-017-3460-8. Epub 2017 Jun 3.
3
Molecular Basis of Congenital Factor XIII Deficiency in Iran.
伊朗先天性因子 XIII 缺乏症的分子基础
Clin Appl Thromb Hemost. 2018 Mar;24(2):210-216. doi: 10.1177/1076029616680473. Epub 2016 Nov 23.
4
Long Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Deficiency Treated Prophylactically with Fibrogammin P®.对一大组接受Fibrogammin P®预防性治疗的先天性因子XIII缺乏症患者的长期随访研究
Iran J Pharm Res. 2016 Spring;15(2):635-40.
5
Laboratory Diagnosis of Factor XIII Deficiency in Developing Countries: An Iranian Experience.发展中国家凝血因子 XIII 缺乏症的实验室诊断：伊朗的经验
Lab Med. 2016 Aug;47(3):220-6. doi: 10.1093/labmed/lmw021. Epub 2016 Jun 26.
6
Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.最大组严重因子XIII缺乏症患者危及生命出血的临床表现及处理
Int J Hematol. 2014 Nov;100(5):443-9. doi: 10.1007/s12185-014-1664-1. Epub 2014 Sep 18.
7
Current understanding in diagnosis and management of factor XIII deficiency.目前对凝血因子 XIII 缺乏症诊断与管理的认识
Iran J Ped Hematol Oncol. 2013;3(4):164-72. Epub 2013 Oct 22.